Bearish Pressure Is Building Around These 3 Stocks
MarketBeat says Hims & Hers (HIMS) missed Q1 revenue and EPS estimates and faces higher customer acquisition costs. It also cites insider selling and notes deals including Novo Nordisk distribution and a $1.15B Eucalyptus acquisition. For QXO, it highlights a widening Q1 net loss and high short interest. For KLA (KLAC), it links the decline to semiconductor/AI sell-off and cyclical capex concerns.


